TGFB1 and pulmonary fibrosis: Activated complement C3a was shown to stimulate human epithelial lung cells to express TGF-β1 [107] and pharmacological blockade of C3ar1 attenuated the development of pulmonary fibrosis in bleomycin-treated mice [108].